Dextran sulfate overlay identifies plaque variants of attenuated type 1 poliovirus with differing marker profiles and neurovirulence in monkeys.
Answers are grounded in this paper and cite their sources.
Distinguishes poliovirus variants by neurovirulence in monkeys; leaves open translation to human vaccine testing.
Summary Analysis of a stock of the NIH reference attenuated, type 1 poliovirus, NA-2 (Sabin strain) by a previously described procedure employing dextran sulfate (dex-s) in the overlay medium, showed that it consisted of three different plaque types. Two of the enhanced (10 mm) and two of the inhibited (less than 1 mm) plaque types were examined for their behavior in tests using the d and rct/40 markers. The enhanced or ds+ virus was found to be d+, rct/40-, whereas the inhibited or ds- virus was d-, rct/40-. One of the ds+ viruses produced histologic lesions of poliomyelitis but no paralysis in a high proportion (55%) of the monkeys after intrathalamic inoculation, whereas the other produced no lesions; the two ds- types caused minimal or no lesions.
No takes yet. Share an insight, caveat, or question.
Takemoto et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: